Upstream anticoagulation for patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the TOTAL trial.
Warren J CantorShahar LaviVladimír DžavíkJohn CairnsAsim N CheemaAnthony Della SiegaRaul MorenoGoran StankovicSasko KedevMadhu K NatarajanYaniv LeviFei YuanSanjit S JollyPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)
Preprocedural anticoagulation is associated with improved flow and reduced thrombus in the IRA prior to PCI, less bailout thrombectomy during PCI but no difference in death, recurrent infarction, or heart failure at 1 year.
Keyphrases
- st elevation myocardial infarction
- percutaneous coronary intervention
- atrial fibrillation
- heart failure
- st segment elevation myocardial infarction
- acute myocardial infarction
- antiplatelet therapy
- coronary artery bypass grafting
- acute coronary syndrome
- coronary artery disease
- venous thromboembolism
- study protocol
- acute ischemic stroke
- phase iii
- coronary artery bypass
- clinical trial
- phase ii
- left ventricular
- randomized controlled trial
- open label